Palvella Therapeutics Inc...

NASDAQ: PVLA · Real-Time Price · USD
47.12
1.02 (2.21%)
At close: Aug 15, 2025, 3:59 PM
48.00
1.88%
After-hours: Aug 15, 2025, 05:20 PM EDT

Palvella Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Cash & Equivalents
70.43M 75.63M 19.36M 19.73M 6.25M 17.4M 32.89M
Short-Term Investments
n/a n/a n/a n/a n/a 8.97M 11.92M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a 287K
Receivables
n/a 1.98M 879K 4.67M 7.25M 6.04M 1.04M
Inventory
n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.31M 1.83M 280K 649K -7.1M 6.28M 13.23M
Total Current Assets
73.75M 79.44M 20.52M 25.05M 6.39M 38.68M 59.09M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a 287K
Total Assets
73.75M 79.44M 20.52M 25.05M 6.39M 38.68M 59.38M
Account Payables
4.56M 4.44M 801K 969K 1.02M 3.37M 2.82M
Deferred Revenue
n/a n/a n/a n/a n/a n/a 994K
Short-Term Debt
n/a n/a n/a n/a n/a n/a 12.29M
Other Current Liabilities
9.62M 3.3M 1.15M 2.27M 602K 2.1M 4.03M
Total Current Liabilities
9.62M 8.98M 4.25M 6.35M 2.73M 11.92M 28.87M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
16.35M 14.88M n/a n/a 9.93M n/a n/a
Total Long-Term Liabilities
16.35M 14.88M n/a n/a 9.93M 9.07M n/a
Total Liabilities
25.97M 23.86M 4.25M 6.35M 12.66M 11.92M 28.87M
Total Debt
n/a n/a n/a n/a n/a n/a 12.29M
Common Stock
11K 11K 1K 1K 1K 98K 99K
Retained Earnings
-111.39M -101.92M -326.33M -323.45M -78.84M -314.96M -310.38M
Comprehensive Income
-111K -3K -316K -436K -346K 28K -339K
Shareholders Equity
47.78M 55.58M 16.27M 18.7M -6.27M 26.76M 30.51M
Total Investments
n/a n/a n/a n/a n/a 8.97M 11.92M